Suppr超能文献

微小 RNA-204 作为儿童先天性心脏病合并肺动脉高压严重程度的指标。

MicroRNA-204 as an Indicator of Severity of Pulmonary Hypertension in Children with Congenital Heart Disease Complicated with Pulmonary Hypertension.

机构信息

Department of Cardiac Surgery, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China (mainland).

出版信息

Med Sci Monit. 2019 Dec 30;25:10173-10179. doi: 10.12659/MSM.917662.

Abstract

BACKGROUND The objective of this study was to investigate the changes and significance of microRNA-204 (miR-204) in children with congenital heart disease (CHD) complicated with pulmonary hypertension (PH). MATERIAL AND METHODS Fifty-two CHD patients with left-to-right shunt were divided into 3 groups according to preoperative pulmonary artery systolic pressure (PASP) detected by color Doppler echocardiography: a control group (PASP <30 mmHg), a mild PH group (PASP 30-49 mmHg), and a severe PH group (PASP >50 mmHg). Peripheral venous blood and supernatant were collected on an empty stomach at 1 h before surgery and 7 days after surgery. The expression of miR-204 in plasma was detected by RT-qPCR. RESULTS One hour before surgery and 7 days after surgery, plasma miR-204 expression was at a higher level than that in the mild PH group and higher than in the severe PH group. miR-204 expression in children in each group showed a decreasing trend after surgery. The mild PH and severe PH groups had lower plasma miR-204 expression and PASP after surgery than before surgery. In the mild PH and severe PH groups, plasma miR-204 expression was negatively correlated with PASP. In all 52 cases, plasma miR-204 expression was negatively correlated with PASP. CONCLUSIONS The plasma miR-204 expression in CHD children with PH was negatively correlated with the degree of PH, suggesting miR-204 may be involved in PH development, and miR-204 expression may be an indicator of PH severity.

摘要

背景

本研究旨在探讨先天性心脏病(CHD)合并肺动脉高压(PH)患儿中 microRNA-204(miR-204)的变化及其意义。

材料和方法

根据彩色多普勒超声心动图检测的术前肺动脉收缩压(PASP),将 52 例左向右分流的 CHD 患者分为 3 组:对照组(PASP <30mmHg)、轻度 PH 组(PASP 30-49mmHg)和重度 PH 组(PASP >50mmHg)。术前 1h 和术后 7d 空腹采集外周静脉血和上清液,采用 RT-qPCR 检测血浆中 miR-204 的表达。

结果

术前 1h 和术后 7d,血浆 miR-204 表达水平均高于轻度 PH 组,高于重度 PH 组。各组患儿术后 miR-204 表达呈下降趋势。与术前相比,轻度 PH 组和重度 PH 组术后血浆 miR-204 表达和 PASP 降低。在轻度 PH 组和重度 PH 组中,血浆 miR-204 表达与 PASP 呈负相关。在 52 例患者中,血浆 miR-204 表达与 PASP 呈负相关。

结论

CHD 合并 PH 患儿的血浆 miR-204 表达与 PH 程度呈负相关,提示 miR-204 可能参与 PH 的发生发展,miR-204 表达可能是 PH 严重程度的指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4716/6951116/5d17839044f0/medscimonit-25-10173-g001.jpg

相似文献

2
The Circulating MicroRNA-206 Level Predicts the Severity of Pulmonary Hypertension in Patients with Left Heart Diseases.
Cell Physiol Biochem. 2017;41(6):2150-2160. doi: 10.1159/000475569. Epub 2017 Apr 20.
4
Role of adrenomedullin in congenital heart disease associated with pulmonary hypertension.
J Huazhong Univ Sci Technolog Med Sci. 2003;23(3):275-7. doi: 10.1007/BF02829512.
6
Plasma Levels of Acylated Ghrelin in Children with Pulmonary Hypertension Associated with Congenital Heart Disease.
Pediatr Cardiol. 2015 Oct;36(7):1423-8. doi: 10.1007/s00246-015-1178-5. Epub 2015 May 17.
9
Echocardiographic estimation of pulmonary arterial systolic pressure in acute heart failure. Prognostic implications.
Eur J Intern Med. 2013 Sep;24(6):562-7. doi: 10.1016/j.ejim.2013.04.009. Epub 2013 May 15.

引用本文的文献

1
Role of miRNA in Cardiovascular Diseases in Children-Systematic Review.
Int J Mol Sci. 2024 Jan 12;25(2):956. doi: 10.3390/ijms25020956.
2
Pulmonary arterial hypertension associated with congenital heart disease: An omics study.
Front Cardiovasc Med. 2023 Mar 10;10:1037357. doi: 10.3389/fcvm.2023.1037357. eCollection 2023.
3
Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension.
Turk J Med Sci. 2023 Feb;53(1):130-141. doi: 10.55730/1300-0144.5566. Epub 2023 Feb 22.
4
Expression of miR-93-5p as a Potential Predictor of the Severity of Chronic Thromboembolic Pulmonary Hypertension.
Biomed Res Int. 2021 Apr 17;2021:6634417. doi: 10.1155/2021/6634417. eCollection 2021.
5
Protective Effect of miR-204 on Doxorubicin-Induced Cardiomyocyte Injury via HMGB1.
Oxid Med Cell Longev. 2020 Nov 19;2020:8819771. doi: 10.1155/2020/8819771. eCollection 2020.

本文引用的文献

1
Clinical diagnostic value of circulating serum miR-509-3p in pulmonary arterial hypertension with congenital heart disease.
Hellenic J Cardiol. 2020 Jan-Feb;61(1):26-30. doi: 10.1016/j.hjc.2018.06.004. Epub 2018 Jun 8.
2
Pulmonary hypertension in congenital heart disease.
Future Cardiol. 2018 Jul;14(4):343-353. doi: 10.2217/fca-2017-0065. Epub 2018 May 24.
3
Pulmonary arterial hypertension in adult congenital heart disease.
Heart. 2018 Oct;104(19):1568-1574. doi: 10.1136/heartjnl-2017-312106. Epub 2018 May 2.
4
Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?
Pulm Circ. 2018 Apr-Jun;8(2):2045893217749114. doi: 10.1177/2045893217749114. Epub 2017 Dec 18.
5
The Circulating MicroRNA-206 Level Predicts the Severity of Pulmonary Hypertension in Patients with Left Heart Diseases.
Cell Physiol Biochem. 2017;41(6):2150-2160. doi: 10.1159/000475569. Epub 2017 Apr 20.
7
The dual regulatory role of miR-204 in cancer.
Tumour Biol. 2016 Sep;37(9):11667-11677. doi: 10.1007/s13277-016-5144-5. Epub 2016 Jul 20.
8
Regulation and function of miR-214 in pulmonary arterial hypertension.
Pulm Circ. 2016 Mar;6(1):109-17. doi: 10.1086/685079.
9
miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2.
Int J Cardiol. 2015 Dec 15;201:38-48. doi: 10.1016/j.ijcard.2015.06.163. Epub 2015 Jul 2.
10
Global genetic analysis in mice unveils central role for cilia in congenital heart disease.
Nature. 2015 May 28;521(7553):520-4. doi: 10.1038/nature14269. Epub 2015 Mar 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验